Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10



Schmidt, M

Neutropenien bei Tumortherapie – aktuelle Aspekte.

Trillium Krebsmedizin. Bd. 31. H. 5. 2022 S. 376-379


Haist, Maximilian; Ries, Frederic; Gunzer, Matthias et al.

Neutrophil-Specific Knockdown of beta 2 Integrins Impairs Antifungal Effector Functions and Aggravates the Course of Invasive Pulmonal Aspergillosis

FRONTIERS IN IMMUNOLOGY. Bd. 13. 2022


Decker, Thomas; Schmidt, Marcus

New Opportunities in Advanced Breast Cancer

ONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. 1-2. 2022 S. 1-2


Huber, Yvonne; Foerster, Friedrich; Moehler, Markus et al.

New Studies at the University Medical Center Mainz on HCC and non-metastatic Colon Carcinoma

GASTROENTEROLOGE. Bd. 17. H. 1. 2022 S. 57-58


Leinert, Elena; Schwentner, Lukas; Janni, Wolfgang et al.

Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy-results from the prospective multi-center BRENDA II study

BREAST CANCER. Bd. 29. H. 3. 2022 S. 429-436


Tilch, Marie-Kristin; Visco, Carlo; Kinda, Sandra et al.

Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry

HEMASPHERE. Bd. 6. H. 5. 2022



Galetzka, Danuta; Boeck, Julia; Wagner, Lukas et al.

p HYPERMETHYLATION OF RAD9A INTRON 2 IN CHILDHOOD CANCER PATIENTS, LEUKEMIA AND TUMOR CELL LINES SUGGEST A ROLE FOR ONCOGENIC TRANSFORMATION

EXCLI JOURNAL. Bd. 21. 2022 S. 117-143